Sutro Biopharma, Inc. (STRO)
NASDAQ: STRO · Real-Time Price · USD
1.770
-0.060 (-3.28%)
At close: Feb 21, 2025, 4:00 PM
1.800
+0.030 (1.69%)
After-hours: Feb 21, 2025, 7:32 PM EST
Sutro Biopharma Stock Forecast
STRO's stock price has decreased by -62.42% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 7 analysts with 12-month price forecasts for Sutro Biopharma stock have an average target of 12.14, with a low estimate of 8.00 and a high estimate of 17. The average target predicts an increase of 585.88% from the current stock price of 1.77.
Analyst Consensus: Strong Buy
* Price targets were last updated on Dec 11, 2024.
Analyst Ratings
The average analyst rating for Sutro Biopharma stock from 7 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 3 | 3 | 3 | 3 |
| Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 7 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JMP Securities | JMP Securities | Buy Reiterates $17 | Buy | Reiterates | $17 | +860.45% | Dec 11, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +577.97% | Nov 18, 2024 |
| Piper Sandler | Piper Sandler | Buy Reiterates $11 | Buy | Reiterates | $11 | +521.47% | Oct 11, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +577.97% | Oct 11, 2024 |
| JMP Securities | JMP Securities | Buy Reiterates $17 | Buy | Reiterates | $17 | +860.45% | Sep 16, 2024 |
Financial Forecast
Revenue This Year
60.18M
from 153.73M
Decreased by -60.85%
Revenue Next Year
55.16M
from 60.18M
Decreased by -8.34%
EPS This Year
-2.96
from -1.78
EPS Next Year
-3.10
from -2.96
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 75.6M | 121.0M | 96.8M | |||
| Avg | 60.2M | 55.2M | 51.4M | |||
| Low | 44.1M | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -50.8% | 101.0% | 75.6% | |||
| Avg | -60.9% | -8.3% | -6.8% | |||
| Low | -71.3% | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -2.55 | -2.11 | -1.83 | |||
| Avg | -2.96 | -3.10 | -2.93 | |||
| Low | -3.18 | -3.82 | -4.24 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.